Wednesday, July 28, 2021

Tatva Chintan Pharma Makes A Stellar Debut, Lists At 95% Premium

Tatva Chintan Pharma IPO was subscribed by a whopping 180.36 times, receiving bids for over 58.83 crore shares against the total issue size of over 32.61 lakh shares

from NDTV Profit - Latest https://ift.tt/3BQefyD
via

No comments:

Post a Comment